Table 6 Frequency of each criterion of MS according to ATP III and IDF in women with and without clinical lipodystrophy
Women | ||||||||
|---|---|---|---|---|---|---|---|---|
ATPIII | IDF | |||||||
MS criteria | Total | Without CL | With CL | p | Total | Without CL | With CL | p |
WC [n, (%)] | 61 (57.5%) | 37 (68.5%) | 24 (46.2%) | 0.020 | 83 (78.3%) | 45 (83.3%) | 38 (73.1%) | 0.200 |
TG [n, (%)] | 78 (73.6%) | 33 (61.1%) | 45 (86.5%) | 0.003 | 78 (73.6%) | 33 (61.1%) | 45 (86.5%) | 0.003 |
HDL [n, (%)] | 72 (67.9%) | 31 (57.4%) | 41 (78.8%) | 0.018 | 72 (67.9%) | 31(57.4%) | 41 (78.8%) | 0.018 |
BP [n, (%)] | 37 (34.9%) | 20 (37.0%) | 17 (32.7%) | 0.639 | 37 (34.9%) | 20 (37.0%) | 17 (32.7%) | 0.639 |
GLU [n, (%)] | 28 (26.4%) | 16 (29.6%) | 12 (23.1%) | 0.444 | 28 (26.4%) | 16 (29.6%) | 12 (23.1%) | 0.444 |
Number of MS criteria | ||||||||
0 | 7 (6.6) | 3 (5.6) | 4 (7.7) | 0.680 | 6 (5.7) | 2 (3.7) | 4 (7.7) | 0.214 |
1 | 15 (14.2) | 10 (18.5) | 5 (9.6) | 12 (11.3) | 8 (14.8) | 4 (7.7) | ||
2 | 34 (32.1) | 16 (29.6) | 18 (34.6) | 26 (24.5) | 16 (29.6) | 10 (19.2) | ||
3 | 16 (15.1) | 8 (14.8) | 8 (15.4) | 25 (23.6) | 10 (18.5) | 15 (28.8) | ||
4 | 25 (23.6) | 14 (25.9) | 11 (21.2) | 26 (24.5) | 15 (27.8) | 11 (21.2) | ||
5 | 9 (8.5) | 3 (5.6) | 6 (11.5) | 11 (10.4) | 3 (5.6) | 8 (15.4) | ||